Based on the provided forecast data for antidepressant medicine sales in Norway, the expected trajectory from 2024 to 2028 shows a steady but slow increase in sales, from 34.5 million USD to 35.4 million USD. Considering that the sales value in 2023 was 34.3 million USD, the year-on-year variation is relatively modest, ranging from a 0.6% to 0.8% increase annually.
Future trends to watch for:
• Increased healthcare awareness and mental health initiatives may boost market growth.
• Potential introduction of new, more effective antidepressants could spur market expansion.
• Economic factors, insurance policies, and patient access to medications will play critical roles in shaping sales trends.
